Abstract
Obstructive sleep apnea-induced hypertension appears to constitute a distinct pathophysiologic entity. Various neurohormonal and inflammatory mediators and hypoxia-induced injury link the two conditions. Obstructive sleep apnea-induced hypertension appears to be reversible in its early phases, but becomes a permanent condition with irreparable vascular changes in later stages. Hence, defining obstructive sleep apnea-induced hypertension and elucidating its role in cardiovascular disease will facilitate appropriate prevention and intervention. This review will clarify the unique set of features of hypertension associated with obstructive sleep apnea and examine the mechanisms that contribute to its cardiovascular consequences.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
